Impact of Coronavirus Disease 2019 Restrictions on Retinal Detachment: A Multicenter Experience

Authors

Jesse J Jung
Jonathan S Chang
Patrick R Oellers
Mohsin H Ali
Brian K Do
Joseph J Tseng
Roberto Roizenblatt
Rajeev H Muni
Christina Y Weng
Zackery B Oakey
Sean W Tsao
Soraya Rofagha
Xavier Chan
Quan V Hoang

Publication Date

7-1-2022

Journal

Ophthalmology Retina

DOI

10.1016/j.oret.2022.02.001

PMID

35144021

PMCID

PMC8820022

PubMedCentral® Posted Date

2-7-2022

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes

Keywords

COVID-19, Communicable Disease Control, Humans, Retinal Detachment, Retrospective Studies, Treatment Outcome, Visual Acuity

Abstract

In this retrospective, multicenter study of 261 eyes (259 patients), patients who underwent rhegmatogenous retinal detachment repair during the coronavirus disease 2019 (COVID-19) post-lockdown period experienced an additional 22-day delay, leading to significantly more epiretinal membrane and proliferative vitreoretinopathy and lower single-surgery anatomic success rates. During lockdown, perfluoropropane gas was used more commonly, and pneumatic retinopexy was used more commonly in COVID-19-positive patients.